Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

402
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
402

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

BJU international·2026
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus Recommendations.

JAMA oncology·2026
Same author

Comparison of the Swedish and Finnish Centers in the European Randomized Study of Screening for Prostate Cancer (ERSPC).

European urology open science·2026
Same author

From Evidence to Implementation: How Should We Screen for Prostate Cancer in the Modern Era?: Editorial to: Nguyen DD, Tadayon B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. 2026. In press. https://doi.org/10.1016/j.eururo.2026.04.005.

European urology·2026
Same author

The PROSA trial: Some Prosaic Comments.

European urology·2026
Same journal

[Access to health data for research].

Lakartidningen·2026
Same journal

[CANVAS and RFC1-related disease - a broad clinical spectrum from cough and neuropathy to cerebellar ataxia].

Lakartidningen·2026
Same journal

[Choosing wisely in Swedish neuroradiology].

Lakartidningen·2026
Same journal

[Asthma among athletes - prevalence, diagnosis and treatment].

Lakartidningen·2026
Same journal

[Minimally invasive surgery for colorectal cancer was introduced in a safe and well controlled manner].

Lakartidningen·2026
Same journal

[Modified Valsalva maneuver induced an asymptomatic polymorphic ventricular tachycardia].

Lakartidningen·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K

[Prostate cancer - diagnostics and screening].

Rebecka Arnsrud Godtman1, Ola Bratt2, Tobias Nordström3

  • 1docent, specialistläkare, verksamhet urologi, Sahlgrenska universitetssjukhuset, Göteborg.

Lakartidningen
|April 22, 2024
PubMed
Summary
This summary is machine-generated.

Prostate cancer screening using prostate-specific antigen (PSA) is debated. Magnetic resonance imaging (MRI) enhances diagnostics, reducing unnecessary biopsies and improving detection of significant prostate cancer.

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

659
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K

Related Experiment Videos

Last Updated: Jun 28, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

659
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K

Area of Science:

  • Oncology
  • Radiology
  • Public Health

Background:

  • Prostate-specific antigen (PSA) screening for prostate cancer reduces mortality but causes overdiagnosis of indolent tumors.
  • Overdiagnosis leads to unnecessary treatments and patient burden.
  • Current screening methods face challenges in balancing benefits and harms.

Purpose of the Study:

  • To evaluate the impact of magnetic resonance imaging (MRI) on prostate cancer diagnostics.
  • To assess the role of organized prostate cancer testing programs in Sweden.
  • To explore future improvements in prostate cancer diagnostics using biomarkers and AI.

Main Methods:

  • Review of recent large studies on MRI in prostate cancer diagnostics.
  • Analysis of outcomes from organized prostate cancer testing programs in Sweden (introduced 2020).
  • Discussion of emerging technologies like biomarkers and artificial intelligence (AI).

Main Results:

  • MRI can spare up to 50% of men with elevated PSA from a biopsy.
  • MRI-guided biopsies increase the detection of clinically significant prostate tumors.
  • Organized screening programs aim for standardized, efficient, and equitable prostate cancer testing.

Conclusions:

  • MRI significantly improves prostate cancer diagnostics, reducing unnecessary biopsies.
  • Organized screening programs enhance testing efficiency and equity.
  • Biomarkers and AI hold promise for future advancements in prostate cancer detection.